Article
Rare and common mutations in hyperlipidemia and atherosclerosis. With special reference to familial defective apolipoprotein B-100.
Scandinavian journal of clinical and laboratory investigation. Supplementum - 1 Jan 1995
Tybjaerg-Hansen A
Abstract excerpt
The aim was to identify genetic determinants for the development of hyperlipidemia and/or atherosclerosis. The present set of studies demonstrates for the first time the clinical expression (phenotype) of a newly discovered monogenic disorder named Familial Defective Apolipoprotein B-100 (FDB). FDB is caused by a G to A mutation in the binding protein (apolipoprotein B-100) for the cholesterol-rich low density...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
